# A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Tenofovir Alafenol Fumarate Tablets (TAF)

> **NCT07002268** · PHASE1 · COMPLETED · sponsor: **Henan Genuine Biotech Co., Ltd.** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Azvudine tablets(FNC) and Tenofovir Alafenol Fumarate Tablets (TAF)
- **DRUG:** Azvudine tablets(FNC) and Tenofovir Alafenol Fumarate Tablets (TAF)
- **DRUG:** Azvudine tablets(FNC) and Tenofovir Alafenol Fumarate Tablets (TAF)

## Key facts

- **NCT ID:** NCT07002268
- **Lead sponsor:** Henan Genuine Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-14
- **Primary completion:** 2022-05-04
- **Final completion:** 2023-08-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07002268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07002268, "A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Tenofovir Alafenol Fumarate Tablets (TAF)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07002268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*